William Roper - DaVita HealthCare Independent Director
| DVA Stock | USD 126.11 1.53 1.20% |
Director
Dr. William L. Roper, M.D., MPH, serves as Independent Director of the DaVita HealthCare Partners Inc. Dr. Roper was one of our directors since May 2001. In January 2019, Dr. Roper became interim president of the University of North Carolina System, North Carolina system of public higher education. Prior to that, Dr. Roper was chief executive officer of the University of North Carolina Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper has also served on the board of directors of Cigna Corporationrationration, a health services corporation, since December 2018. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004, he was dean of the UNC School of Public Health. Before joining UNC in 1997, Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993, on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a nonprofit organization that aims to improve the quality of healthcare. From December 2007 to November 2011, Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and from November 2011 until December 2018 served on the board of its successor company, Express Scripts Holding Company since 2001.
| Age | 69 |
| Tenure | 23 years |
| Address | 2000 16th Street, Denver, CO, United States, 80202 |
| Phone | 720 631 2100 |
| Web | https://www.davita.com |
DaVita HealthCare Management Efficiency
The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 10.6 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Paglia | Simulations Plus | 48 | |
| Robert Musslewhite | Evolent Health | 44 | |
| David DArgenio | Simulations Plus | 64 | |
| Linda Rebrovick | HealthStream | 62 | |
| Michael Valentine | Streamline Health Solutions | 47 | |
| Allen Moseley | Streamline Health Solutions | 46 | |
| Thompson Dent | HealthStream | 68 | |
| David Ralph | Simulations Plus | 68 | |
| Cheryl Scott | Evolent Health | 70 | |
| Martin Harris | HealthStream | 61 | |
| Matthew Hobart | Evolent Health | 47 | |
| Michael Kaplan | Streamline Health Solutions | 50 | |
| Lisa LaVange | Simulations Plus | N/A | |
| Frank Gordon | HealthStream | 55 | |
| Bridget Duffy | Evolent Health | 60 | |
| Dale Polley | HealthStream | 67 | |
| Kim Keck | Evolent Health | 56 | |
| Kenneth Samet | Evolent Health | 60 | |
| David Farner | Evolent Health | 56 | |
| Diane Patrick | Agiliti | 69 | |
| Kenan Lucas | Streamline Health Solutions | 33 | |
Management Performance
| Return On Equity | 0.39 | ||||
| Return On Asset | 0.0592 |
DaVita HealthCare Leadership Team
Elected by the shareholders, the DaVita HealthCare's board of directors comprises two types of representatives: DaVita HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DaVita. The board's role is to monitor DaVita HealthCare's management team and ensure that shareholders' interests are well served. DaVita HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DaVita HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Hearty, Chief Compliance Officer | ||
| Shawn Guertin, Director | ||
| Javier Rodriguez, Chief Executive Officer, Director | ||
| Paula Price, Independent Director | ||
| James Hilger, Interim CFO and Chief Accounting Officer | ||
| Paul Diaz, Independent Director | ||
| Misha Palecek, Chief Business | ||
| Christopher Berry, Group Officer | ||
| Jeffrey Giullian, Chief Care | ||
| Robert Lang, President International Business | ||
| John Nehra, Independent Director | ||
| Peter Grauer, Lead Independent Director | ||
| Phyllis Yale, Independent Director | ||
| Craig Samitt, Executive Vice President; CEO of HealthCare Partners | ||
| Robert Margolis, Co-Chairman of the Board | ||
| Joseph Mello, COO of HealthCare Partners | ||
| Jim Gustafson, Vice President - Investor Relations | ||
| John Winstel, Chief Accounting Officer, Group Vice President | ||
| Roger Valine, Independent Director | ||
| Kenneth Smith, Chief Officer | ||
| Gregory Moore, Independent Director | ||
| David Roer, Chief Medical Officer - DaVita Integrated Kidney Care | ||
| FRCPC MD, Chief Operations | ||
| Atul Mathur, Executive Vice President of Global Operations | ||
| Joel Ackerman, Chief Financial Officer, Treasurer | ||
| Kathleen Waters, Chief Legal and Public Affairs Officer | ||
| Pamela Arway, Independent Chairman of the Board | ||
| Michael Staffieri, Chief Operating Officer- DaVita Kidney Care | ||
| Pascal Desroches, Independent Director | ||
| LeAnne Zumwalt, Group Vice President - purchasing and government affairs | ||
| Kenny Gardner, Chief People Officer - DaVita Kidney Care | ||
| Kim Rivera, Chief Legal Officer | ||
| Carol Davidson, Independent Director | ||
| Barbara Desoer, Independent Director | ||
| Dennis Kogod, CEO of International and President of Healthcare Partners | ||
| William Roper, Independent Director | ||
| Mihran Naljayan, Chief Medical Officer - Home Modalities | ||
| Charles Berg, Independent Director | ||
| Jeanine Jiganti, Chief Compliance Officer | ||
| Laura Mildenberger, Chief People Officer - Kidney Care | ||
| MSc MD, Chief International | ||
| Kent Thiry, Chairman, CEO and CEO of Healthcare Partners |
DaVita Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DaVita HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.39 | ||||
| Return On Asset | 0.0592 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 23.79 B | ||||
| Shares Outstanding | 87.32 M | ||||
| Shares Owned By Insiders | 45.06 % | ||||
| Shares Owned By Institutions | 51.58 % | ||||
| Number Of Shares Shorted | 4.14 M | ||||
| Price To Earning | 11.43 X |
DaVita HealthCare Investors Sentiment
The influence of DaVita HealthCare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in DaVita. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to DaVita HealthCare's public news can be used to forecast risks associated with an investment in DaVita. The trend in average sentiment can be used to explain how an investor holding DaVita can time the market purely based on public headlines and social activities around DaVita HealthCare Partners. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
DaVita HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for DaVita HealthCare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average DaVita HealthCare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on DaVita HealthCare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DaVita HealthCare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DaVita HealthCare's short interest history, or implied volatility extrapolated from DaVita HealthCare options trading.
Pair Trading with DaVita HealthCare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DaVita HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will appreciate offsetting losses from the drop in the long position's value.Moving together with DaVita Stock
| 0.95 | ELMD | Electromed | PairCorr |
| 0.84 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.89 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
Moving against DaVita Stock
| 0.94 | IVP | Inspire Veterinary | PairCorr |
| 0.82 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.81 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.79 | NVST | Envista Holdings Corp Financial Report 1st of May 2024 | PairCorr |
| 0.77 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
The ability to find closely correlated positions to DaVita HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DaVita HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DaVita HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DaVita HealthCare Partners to buy it.
The correlation of DaVita HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DaVita HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DaVita HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DaVita HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.2 | Earnings Share 7.42 | Revenue Per Share 133.717 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0592 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.